Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery
NCT00586976Phase 3Terminated
- Sponsor
- Mayo Clinic
- Start
- Jul 2005
- Primary completion
- Jun 2007
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Mayo Clinic. Primary endpoint: Visual Analog Pain Score at 64 hours. Started Jul 2005; status: terminated.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00586976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586976.